[Perioperative antibiotic prophylaxis in dermatosurgery-2019 status quo].

Perioperative Antibiose in der Dermatochirurgie – Stand 2019.

Journal

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
ISSN: 1432-1173
Titre abrégé: Hautarzt
Pays: Germany
ID NLM: 0372755

Informations de publication

Date de publication:
Nov 2019
Historique:
pubmed: 29 9 2019
medline: 20 11 2019
entrez: 28 9 2019
Statut: ppublish

Résumé

Perioperative antibiotic prophylaxis (PAP) is determined as a short-term, in general single-shot administration of an antibiotic prior to a surgical intervention. The main goal of PAP is to reduce postoperative surgical site infections. In addition, PAP is administered to avoid development of bacterial endocarditis in patients who are at high risk. Regarding the increasing prescription of antibiotics by dermatologists and the rising emergence of resistant bacterial strains, a rational use of PAP in dermatosurgery has to be demanded. Thus, identification of risk factors being determined either by the patient, the type of surgery or the location will help to identify those patients requiring PAP. Moreover, utilizing established criteria will avoid the unnecessary administration of PAP-which only creates a false sense of safety.

Identifiants

pubmed: 31560081
doi: 10.1007/s00105-019-04485-2
pii: 10.1007/s00105-019-04485-2
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Review

Langues

ger

Sous-ensembles de citation

IM

Pagination

842-849

Références

J Dtsch Dermatol Ges. 2017 Feb;15(2):117-148
pubmed: 28214321
Cochrane Database Syst Rev. 2017 May 18;5:CD012462
pubmed: 28516472
J Am Acad Dermatol. 1995 Feb;32(2 Pt 1):155-76; quiz 177-80
pubmed: 7829698
BMJ. 2009 Feb 10;338:b516
pubmed: 19208704
Dermatol Surg. 2018 Dec;44(12):1525-1536
pubmed: 30045108
J Hosp Infect. 2007 Mar;65(3):258-63
pubmed: 17244515
Hautarzt. 2014 Jan;65(1):32-8
pubmed: 24337238
JAMA Dermatol. 2019 Apr 1;155(4):465-470
pubmed: 30825412
J Dermatol. 2013 Oct;40(10):779-85
pubmed: 23961937
Joint Bone Spine. 2016 Dec;83(6):701-705
pubmed: 27118016
Br J Dermatol. 2005 Nov;153(5):967-71
pubmed: 16225607
Dermatol Surg. 2015 May;41(5):537-49
pubmed: 25888316
Surg Clin North Am. 1980 Feb;60(1):27-40
pubmed: 7361226
Dermatol Surg. 1995 Jun;21(6):509-14
pubmed: 7773598
Med Oral Patol Oral Cir Bucal. 2008 Jun 01;13(6):E355-62
pubmed: 18521055
Lancet Infect Dis. 2005 Dec;5(12):751-62
pubmed: 16310147
J Am Acad Dermatol. 2008 Sep;59(3):464-73
pubmed: 18694679
Br J Dermatol. 2018 Feb;178(2):394-399
pubmed: 29193009
Eur Heart J. 2015 Nov 21;36(44):3075-3128
pubmed: 26320109
Acta Derm Venereol. 2018 Feb 7;98(2):246-250
pubmed: 29136259
J Dtsch Dermatol Ges. 2019 Jul;17(7):703-715
pubmed: 31364303
Dermatol Surg. 2006 Jun;32(6):819-26; discussion 826-7
pubmed: 16792648
N Engl J Med. 2002 Jun 13;346(24):1871-7
pubmed: 12063371
Arch Dermatol. 2007 Oct;143(10):1267-71
pubmed: 17938340
J Am Acad Dermatol. 2008 Aug;59(2):275-8
pubmed: 18638628
Hautarzt. 2001 Jul;52(7):609-14
pubmed: 11475641

Auteurs

J Lammer (J)

Fakultät für Medizin, Klinik und Poliklinik für Dermatologie und Allergologie, Technische Universität München, 80802, München, Deutschland.

A Böhner (A)

Fakultät für Medizin, Klinik und Poliklinik für Dermatologie und Allergologie, Technische Universität München, 80802, München, Deutschland.

T Volz (T)

Fakultät für Medizin, Klinik und Poliklinik für Dermatologie und Allergologie, Technische Universität München, 80802, München, Deutschland. thomas.volz@tum.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH